Tapera Talent, Odimegwu Clifford, Makoni Tatenda, Mukuwapasi Waraidzo, Chitiyo Vivian, Kadziyanike Gilton, Mutsinze Abigail, Willis Nicola, Chemhaka Garikayi, Phiri Million
Demography and Population Studies Programme, Schools of Public Health and Social Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Zimbabwe National Network of People Living with HIV (ZNNP+), Harare, Zimbabwe.
J Public Health Afr. 2025 Mar 11;16(1):664. doi: 10.4102/jphia.v16i1.664. eCollection 2025.
Several studies have now highlighted COVID-19 vaccination hesitancy in the public. However, not much is known about COVID-19 vaccination amoung people living with HIV (PLHIV).
This study aimed to examine the predisposition of PLHIV on antiretroviral therapy to utilise the COVID-19 vaccine.
The study was done in urban and rural communities of Zimbabwe.
The study utilised a concurrent triangulation design of which only one data collection phase was used. The quantitative data were collected from 2157 PLHIV on antiretroviral viral therapy through a structured interviewer-administered questionnaire. On the other hand, qualitative data were collected through in-depth interviews.
The study found a higher proportion of COVID-19 vaccine utilisation among adults in comparison to adolescents and young people. Fear of side effects contributed to the most common reason for not getting vaccinated. Adolescents aged 15-19 years were significantly less likely to receive the COVID-19 vaccine (adjusted odds ratios [aOR] = 0.58; 95% CI: 0.41-0.83). Being a previous contact of a COVID-19 case was significantly associated with higher odds of COVID-19 vaccination (aOR = 3.43; 95% CI: 1.92-6.10). Additionally, living in a rural area was associated with higher odds of COVID-19 vaccination among PLHIV (aOR = 1.38; 95% CI: 1.05-1.83).
There is need to broaden to speak to the role of families, communities and healthcare workers ensuring adolescent and youth-friendly information and support for vaccinations.
The COVID-19 vaccination rates were lower among adolescents and young people compared to adults living with HIV. Adolescents and young people face challenges in accessing adolescent-friendly health services.
多项研究现已凸显公众对新冠病毒疫苗接种的犹豫态度。然而，对于感染艾滋病毒者（PLHIV）的新冠病毒疫苗接种情况，我们所知甚少。
本研究旨在调查接受抗逆转录病毒治疗的PLHIV接种新冠病毒疫苗的倾向。
该研究在津巴布韦的城乡社区开展。
本研究采用了同步三角测量设计，仅使用了一个数据收集阶段。通过由访谈员执行的结构化问卷，从2157名接受抗逆转录病毒治疗的PLHIV中收集定量数据。另一方面，通过深入访谈收集定性数据。
研究发现，与青少年相比，成年人中新冠病毒疫苗的接种比例更高。担心副作用是未接种疫苗的最常见原因。15至19岁的青少年接种新冠病毒疫苗的可能性显著较低（调整后的优势比[aOR]=0.58；95%置信区间：0.41-0.83）。曾与新冠病毒病例有过接触与更高的新冠病毒疫苗接种几率显著相关（aOR=3.43；95%置信区间：1.92-6.10）。此外，居住在农村地区与PLHIV中更高的新冠病毒疫苗接种几率相关（aOR=1.38；95%置信区间：1.05-1.83）。
有必要扩大范围，探讨家庭、社区和医护人员在确保提供适合青少年的疫苗接种信息和支持方面的作用。
与感染艾滋病毒的成年人相比，青少年和年轻人中的新冠病毒疫苗接种率较低。青少年在获得适合青少年的医疗服务方面面临挑战。
Zotero 插件